CD52-directed Cytolytic Antibody [EPC] - N0000175659
Pharmacologic Class Information
Pharmacologic Code | N0000175659 |
Pharmacologic Name | CD52-directed Cytolytic Antibody |
Pharmacologic Uses |
|
Pharmacologic Concept | Established Pharmacologic Classes - [EPC] |
Pharmacologic Concept Description | An established pharmacologic class is a term or phrase that is scientifically valid
and clinically meaningful according to the following definitions:
|
NDC Products with CD52-directed Cytolytic Antibody
The table contains 2 products whose active ingredient are classified under the same pharmacologic class CD52-directed Cytolytic Antibody [EPC].
NDC | Proprietary Name | Non-Proprietary Name | Dosage Form | Route Name | Company Name | Status | |
---|---|---|---|---|---|---|---|
58468-0200 | Lemtrada | Non-Proprietary Name: Alemtuzumab | Injection, Solution, Concentrate | Intravenous | Genzyme Corporation | ACTIVE | |
58468-0357 | Campath | Non-Proprietary Name: Alemtuzumab | Injection | Intravenous | Genzyme Corporation | ACTIVE |